VeroScience Continues To Explore Clinical Benefits Of Circadian Neuroendocrine Resetting Therapy With Six Papers Presented At 2016 American Diabetes Association Scientific Sessions June 10-14

Press/Media: Press / Media

PeriodJun 13 2016

Media coverage

1

Media coverage

  • TitleVeroScience Continues To Explore Clinical Benefits Of Circadian Neuroendocrine Resetting Therapy With Six Papers Presented At 2016 American Diabetes Association Scientific Sessions June 10-14
    Media name/outletBioSpace
    CountryUnited States
    Date6/13/16
    PersonsRalph A Defronzo